查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1777372

全球静脉输液帮浦市场

Intravenous Infusion Pumps
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 307 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球静脉输液帮浦市场规模将达 85 亿美元

全球静脉输液帮浦市场规模预计在2024年为60亿美元，预计到2030年将达到85亿美元，2024年至2030年的复合年增长率为5.8%。容量输液帮浦是本报告分析的细分市场之一，预计其复合年增长率为5.1%，到分析期结束时规模将达到25亿美元。胰岛素输液帮浦细分市场在分析期间的复合年增长率估计为5.0%。

美国市场预计将达到 16 亿美元，中国市场复合年增长率将达到 9.0%

美国静脉输液帮浦市场规模预计2024年达到16亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到17亿美元，在2024-2030年的分析期间内，复合年增长率为9.0%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为2.9%和5.7%。在欧洲，预计德国市场的复合年增长率为3.8%。

全球静脉输液帮浦市场－主要趋势与驱动因素摘要

静脉输液帮浦如何改变患者照护？

由于精准药物输送、医疗自动化以及输液技术进步的需求不断增长，静脉输液帮浦市场正在经历显着成长。静脉输液帮浦是关键的医疗设备，用于将可控剂量的液体、药物和营养物质直接输送到患者血液中。它们在医院、门诊手术中心、居家医疗和加护病房(ICU) 等需要持续输液、化疗、疼痛管理和水合疗法的场所中发挥着至关重要的作用。

随着糖尿病、癌症和心血管疾病等慢性疾病的发生率不断上升，静脉输液帮浦已成为患者长期管理的必需品。此外，智慧输液帮浦、无线连接和AI辅助剂量调整等技术创新正在彻底改变医院工作流程、病人安全和用药准确性。

新冠疫情进一步加速了静脉输液帮浦的普及，医院对自动化、远端监控输液系统的需求日益增长，旨在最大限度地减少护理师工作量，加强感染控制，并优化重症监护室（ICU）环境下的患者管理。随着医疗服务提供者持续重视自动化、病患安全以及与数位医疗系统的集成，预计未来几年输液帮浦市场将快速成长。

推动输液帮浦市场发展的主要趋势是什么？

输液帮浦市场最具变革性的趋势之一是智慧输液帮浦的兴起。这些人工智慧驱动的可程式设计输液系统配备了给药错误减少系统 (DERS)、即时药物库和无线连接，以确保精准用药，同时减少人为错误。智慧型输液帮浦越来越多地与电子健康记录(EHR) 和临床决策支援系统 (CDSS) 集成，以改善工作流程自动化并优化用药管理。

另一个主要趋势是门诊输液帮浦在居家照护的应用日益广泛。随着居家医疗保健和门诊照护的日益普及，轻便便携的可穿戴式输液帮浦正被用于慢性病管理、化疗、疼痛缓解等。这一趋势与个人化、以患者为中心的护理模式的转变相呼应，这种模式在传统的医院环境之外提供医疗服务。

无线监控与物联网输液帮浦的整合也正在彻底改变整个产业。现代输液帮浦可将资料即时传输到医院网路或云端基础平台，从而实现输液速率的远端监控、剂量差异的早期检测以及预测性维护警报。这项技术提高了病人安全性，减轻了护理人员的工作量，并最大限度地减少了用药错误。

此外，机器人辅助输液帮浦和人工智慧给药演算法也已开发出来，以提高药物输送的准确性并防止过量用药。人工智慧输液系统可以分析患者的生命征象、药物交互作用和先前用药模式，从而动态调整输液速率，尤其是在重症加护和麻醉管理领域。

另一个新兴趋势是一次性和无针输液系统的发展。出于对感染控制、交叉污染和针刺伤的担忧，製造商正在推出一次性和封闭式系统输液泵，尤其是在肿瘤学、免疫治疗和新生儿护理领域。这些创新符合医院安全通讯协定和感染预防指南。

影响输液帮浦市场的挑战有哪些？

儘管静脉输液技术发展迅速，但市场仍面临许多挑战，包括设备成本高、维护复杂性以及监管障碍。其中最大的担忧是智慧型输液帮浦和先进给药系统的高成本。虽然这些设备能够提高准确性和安全性，但它们需要在医院基础设施、培训和网路安全方面投入巨额资金，因此中小型医疗机构难以采用。

另一个重大挑战是输液帮浦错误和设备故障。程式错误、机械故障和软体故障已导致严重的用药错误、过量用药和剂量不足事件，并引发产品召回和监管审查。美国食品药物管理局 (FDA) 和其他卫生机构已发布有关输液帮浦故障的安全警告，敦促製造商改善品管、错误预防演算法和使用者培训。

随着物联网和无线输液帮浦的普及，网路安全威胁和资料漏洞构成了另一个挑战。针对医院网路的骇客可能会操纵输液速率或洩露患者数据，导致严重的健康风险和责任问题。医疗机构必须实施强大的网路安全通讯协定、加密技术并定期更新软体，以防止输液设备遭受潜在的网路攻击。

复杂的设备互通性以及与医院IT系统的整合也阻碍了其应用。许多医院仍在使用过时的电子健康记录(EHR) 系统，这使得智慧型输液帮浦难以与现有基础设施无缝整合。需要进行标准化工作，以确保不同医疗平台之间资料交换的顺畅和相容性。

此外，严格的监管核准和合规要求也延缓了新型输液帮浦的上市。输液帮浦必须符合FDA、CE（欧洲）和ISO（国际标准化组织）关于安全性、剂量准确性和软体可靠性的严格标准。冗长的核准流程增加了创新输液设备的研发成本和上市时间。

哪些因素推动了静脉输液帮浦市场的成长？

输液帮浦市场的成长受到多种因素的推动，包括慢性病盛行率的上升、医疗技术的进步以及对自动化药物输送日益增长的需求。其中最大的驱动因素之一是对精准可控的药物给药的需求日益增长，尤其是在重症加护、肿瘤科和新生儿护理领域。配备安全机制的智慧输液帮浦有助于减少用药错误，已成为重症监护室、手术室和儿科病房等高风险环境中的必备设备。

另一个主要驱动因素是家庭和门诊输液治疗的日益普及。患有糖尿病、癌症和自体免疫疾病等慢性疾病的患者通常需要长期输液治疗，这推动了对携带式和可穿戴式输液泵的需求，这些输液泵可在院外进行治疗。老年人口的成长和远距远端医疗服务的兴起进一步推动了这一趋势。

肠外营养和疼痛管理解决方案日益增长的需求也推动了市场的成长。营养不良、胃肠道疾病和术后恢復的患者需要透过输液帮浦进行静脉营养，增加了对专用肠内和肠外输液设备的需求。同样，患者自控镇痛 (PCA) 帮浦在术后和安宁疗护环境中用于非鸦片类药物疼痛管理也越来越受欢迎。

新兴市场的政府措施和医疗基础设施现代化计划也在推动市场扩张。亚太、拉丁美洲和中东地区的国家正在投资先进的医院设备、数位健康解决方案和智慧输液系统，以加强患者照护并减少医院併发症。

此外，个人化医疗和药物传递的兴起，也推动了对用于基因治疗、免疫治疗和标靶癌症治疗的专用输液系统的需求。随着复杂生物製药的研发管线不断扩大，製药公司正与医疗设备製造商合作，开发用于精准给药的下一代输液技术。

结论输液帮浦技术的未来

随着医疗机构、居家照护机构和製药公司采用更智慧、更安全、更有效率的药物输送系统，输液帮浦市场预计将持续成长。随着人工智慧、机器人技术和数位健康整合技术的进步，输液帮浦将在个人化医疗、自动化药物管理和远端患者监护发挥越来越重要的作用。

在不断发展的输液治疗领域，重视设备安全、网路安全、法规遵循和无缝医院整合的製造商将拥有竞争优势。随着精准、微创和互联输液系统的需求日益增长，输液治疗的未来将由自动化、以患者为中心的解决方案和先进的数位健康生态系统定义。

部分

产品（容积式输液帮浦、胰岛素输液帮浦、注射输液帮浦帮浦、肠内输液帮浦、门诊输液帮浦、病人自控镇痛、植入式输液帮浦等）、适应症（化疗、糖尿病、胃肠病学、止痛/疼痛管理、小儿科/新生儿科、血液学等）

受访公司范例

  • Alaris（part of BD）
  • Autoinfu
  • B. Braun Infusomat
  • B. Braun Melsungen AG
  • Baxter International
  • Baxter Sigma Spectrum
  • BD（Becton, Dickinson and Company）
  • Biomedix Medical, Inc.
  • DiaMedical USA
  • Fresenius Kabi
  • ICU Medical
  • IRadimed Corporation
  • Med One Group
  • Medtronic plc
  • Moog Inc.
  • Moog Medical Devices Group
  • Smiths Medical
  • Terumo Corporation
  • Zyno Medical

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循查询 LLM 或特定产业SLM 的典型规范，而是建立了一个来自世界各地领域专家的精选内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP31679

Global Intravenous Infusion Pumps Market to Reach US$8.5 Billion by 2030

The global market for Intravenous Infusion Pumps estimated at US$6.0 Billion in the year 2024, is expected to reach US$8.5 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Volumetric Infusion Pumps, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Insulin Infusion Pumps segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 9.0% CAGR

The Intravenous Infusion Pumps market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Intravenous Infusion Pump Market - Key Trends & Drivers Summarized

How Are Intravenous Infusion Pumps Transforming Patient Care?

The intravenous (IV) infusion pump market is experiencing significant growth due to the increasing demand for precision drug delivery, automation in healthcare, and advancements in infusion technology. IV infusion pumps are critical medical devices used to deliver fluids, medications, and nutrients directly into a patient’s bloodstream in controlled amounts. They play a vital role in hospitals, ambulatory surgical centers, home healthcare, and intensive care units (ICUs) for conditions requiring continuous drug infusion, chemotherapy, pain management, and hydration therapy.

With the rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders, IV infusion pumps have become essential for long-term patient management. Additionally, technological innovations such as smart infusion pumps, wireless connectivity, and AI-driven dosage adjustments are revolutionizing hospital workflows, patient safety, and drug administration accuracy.

The COVID-19 pandemic further accelerated the adoption of IV infusion pumps, as hospitals faced an increased demand for automated and remotely monitored infusion systems to minimize nurse workload, enhance infection control, and optimize patient management in ICU settings. As healthcare providers continue to prioritize automation, patient safety, and integration with digital health systems, the IV infusion pump market is expected to grow rapidly in the coming years.

What Are the Key Trends Driving the IV Infusion Pump Market?

One of the most transformative trends in the IV infusion pump market is the rise of smart infusion pumps. These AI-driven and programmable infusion systems come with dose error reduction systems (DERS), real-time drug libraries, and wireless connectivity, ensuring precise medication administration while reducing human errors. Smart pumps are increasingly being integrated with electronic health records (EHRs) and clinical decision support systems (CDSS) to improve workflow automation and optimize medication dosing.

Another major trend is the increasing adoption of ambulatory infusion pumps for home-based therapy. As home healthcare and outpatient treatment gain popularity, lightweight, portable, and wearable infusion pumps are being used for chronic disease management, chemotherapy, and pain relief treatments. This trend aligns with the shift toward personalized and patient-centric care models, where individuals receive treatment outside of traditional hospital settings.

The integration of wireless monitoring and IoT-enabled infusion pumps is also revolutionizing the industry. Modern IV infusion pumps transmit real-time data to hospital networks and cloud-based platforms, allowing remote monitoring of infusion rates, early detection of dosage discrepancies, and predictive maintenance alerts. This technology enhances patient safety, reduces nurse workload, and minimizes medication errors.

Additionally, robotic-assisted infusion pumps and AI-powered dosing algorithms are being developed to improve drug administration accuracy and prevent overdose risks. AI-driven infusion systems analyze patient vitals, drug interactions, and historical dosage patterns to adjust infusion rates dynamically, particularly in critical care and anesthesia management.

Another emerging trend is the development of disposable and needle-free infusion systems. Concerns over infection control, cross-contamination, and needle-stick injuries have driven manufacturers to introduce single-use and closed-system infusion pumps, particularly for oncology, immunotherapy, and neonatal care applications. These innovations align with hospital safety protocols and infection prevention guidelines.

What Challenges Are Impacting the IV Infusion Pump Market?

Despite the rapid advancements in IV infusion technology, the market faces several challenges, including high device costs, maintenance complexity, and regulatory hurdles. One of the biggest concerns is the high cost of smart infusion pumps and advanced drug delivery systems. While these devices enhance accuracy and safety, they require significant investment in hospital infrastructure, training, and cybersecurity, making adoption difficult for small and mid-sized healthcare facilities.

Another key challenge is infusion pump errors and device malfunctions. Programming errors, mechanical failures, and software glitches have resulted in serious medication errors, overdoses, and under-dosing incidents, leading to product recalls and regulatory scrutiny. The FDA and other health agencies have issued safety alerts regarding infusion pump malfunctions, prompting manufacturers to improve quality control, error prevention algorithms, and user training.

Cybersecurity threats and data vulnerabilities pose another challenge, as IoT-enabled and wireless infusion pumps become more common. Hackers targeting hospital networks could manipulate infusion rates or compromise patient data, leading to serious health risks and liability concerns. Healthcare facilities must implement robust cybersecurity protocols, encryption technologies, and regular software updates to prevent potential cyberattacks on infusion devices.

Complexity in device interoperability and integration with hospital IT systems also hinders adoption. Many hospitals still operate with legacy electronic health record (EHR) systems, making it difficult to seamlessly integrate smart IV pumps with existing infrastructure. Standardization efforts are needed to ensure smooth data exchange and compatibility across different healthcare platforms.

Additionally, stringent regulatory approvals and compliance requirements delay the introduction of new infusion pump models. IV infusion pumps must meet strict FDA, CE (Europe), and ISO (International Organization for Standardization) guidelines regarding safety, dosage accuracy, and software reliability. The lengthy approval process increases R&D costs and time-to-market for innovative infusion devices.

What Factors Are Driving the Growth of the IV Infusion Pump Market?

The growth in the IV infusion pump market is driven by several factors, including the rising prevalence of chronic diseases, advancements in medical technology, and increasing demand for automation in drug delivery. One of the biggest drivers is the growing need for precise and controlled medication administration, particularly in critical care, oncology, and neonatal care. Smart infusion pumps equipped with safety mechanisms help reduce medication errors, making them essential in high-risk environments such as ICUs, operating rooms, and pediatric wards.

Another major driver is the increasing adoption of home-based and ambulatory infusion therapy. Patients with chronic conditions such as diabetes, cancer, and autoimmune disorders often require long-term infusion therapy, leading to the rising demand for portable and wearable IV pumps that enable treatment outside hospital settings. The growing elderly population and the rise of telehealth services further support this trend.

The increasing demand for parenteral nutrition and pain management solutions is also propelling market growth. Patients suffering from malnutrition, gastrointestinal disorders, or post-operative recovery require intravenous feeding via infusion pumps, driving demand for specialized enteral and parenteral infusion devices. Similarly, patient-controlled analgesia (PCA) pumps are gaining popularity for opioid-free pain management in post-surgical and palliative care.

Government initiatives and healthcare infrastructure modernization projects in emerging markets are also fueling market expansion. Countries across Asia-Pacific, Latin America, and the Middle East are investing in advanced hospital equipment, digital health solutions, and smart infusion systems to enhance patient care and reduce hospital-acquired complications.

Furthermore, the rise of personalized medicine and biologic drug delivery is driving demand for specialized infusion systems designed for gene therapy, immunotherapy, and targeted cancer treatments. With the growing pipeline of complex biologic drugs, pharmaceutical companies are partnering with medical device manufacturers to develop next-generation infusion technologies for precision drug administration.

Conclusion: The Future of IV Infusion Pump Technology

The IV infusion pump market is poised for continued growth as healthcare facilities, home-based care providers, and pharmaceutical companies adopt smarter, safer, and more efficient drug delivery systems. With ongoing innovations in AI, robotics, and digital health integration, IV pumps will play an increasingly critical role in personalized medicine, automated drug administration, and remote patient monitoring.

Manufacturers that prioritize device safety, cybersecurity, regulatory compliance, and seamless hospital integration will gain a competitive edge in the evolving infusion therapy landscape. As demand for precision-based, minimally invasive, and connected infusion systems rises, the future of IV therapy will be defined by automation, patient-centric solutions, and advanced digital health ecosystems.

SCOPE OF STUDY:

The report analyzes the Intravenous Infusion Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps, Others); Disease Indication (Chemotherapy, Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

  • Alaris (part of BD)
  • Autoinfu
  • B. Braun Infusomat
  • B. Braun Melsungen AG
  • Baxter International
  • Baxter Sigma Spectrum
  • BD (Becton, Dickinson and Company)
  • Biomedix Medical, Inc.
  • DiaMedical USA
  • Fresenius Kabi
  • ICU Medical
  • IRadimed Corporation
  • Med One Group
  • Medtronic plc
  • Moog Inc.
  • Moog Medical Devices Group
  • Smiths Medical
  • Terumo Corporation
  • Zyno Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Intravenous Infusion Pumps - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Hospitalization Rates and Critical Care Admissions Drive Demand for Intravenous Infusion Pumps
    • Increasing Prevalence of Chronic Diseases and Long-Term Therapies Expands Use of Infusion Pumps in Homecare
    • Growth in Geriatric Population Sustains Demand for Continuous and Controlled Drug Delivery Systems
    • Technological Advancements in Smart Pumps Enhance Safety, Monitoring, and Drug Delivery Precision
    • Integration With EMR and Medication Management Systems Strengthens the Business Case for Smart Infusion Devices
    • Growing Incidence of Medication Errors Spurs Adoption of Dose Error Reduction Systems (DERS) in Infusion Pumps
    • Expansion of Ambulatory and Day-Care Procedures Fuels Demand for Portable and Wearable Infusion Pumps
    • Surge in Chemotherapy, Parenteral Nutrition, and Pain Management Therapies Drives Use in Specialty Care
    • Adoption of Wireless Connectivity and Remote Monitoring Features Creates Differentiation in High-Acuity Settings
    • Increased Investment in Hospital Automation and Digital Infrastructure Propels Infusion System Modernization
    • High Demand for Battery-Powered and Multi-Channel Pumps Enhances Versatility Across Care Settings
    • Growing Focus on Patient-Centric Care Models Drives Development of User-Friendly and Intuitive Pump Interfaces
    • Regulatory Emphasis on Infusion Pump Safety and Post-Market Surveillance Strengthens Product Quality Standards
    • Emergence of Closed-Loop and Autonomous Infusion Technologies Drives R&D Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intravenous Infusion Pumps Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intravenous Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Intravenous Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Volumetric Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Volumetric Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Volumetric Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Insulin Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Insulin Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Insulin Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Syringe Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Syringe Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Syringe Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Enteral Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Enteral Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Enteral Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Ambulatory Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Patient Controlled Analgesia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Patient Controlled Analgesia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Patient Controlled Analgesia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Implantable Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Implantable Infusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Implantable Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Gastroenterology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Analgesia / Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Analgesia / Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Analgesia / Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Pediatrics / Neonatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Pediatrics / Neonatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Pediatrics / Neonatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • JAPAN
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • CHINA
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • EUROPE
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Intravenous Infusion Pumps by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Intravenous Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • FRANCE
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • GERMANY
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 107: Spain Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Spain Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Spain 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Spain 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 113: Russia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Russia Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Russia 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 116: Russia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Russia Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Russia 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Intravenous Infusion Pumps by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Asia-Pacific 15-Year Perspective for Intravenous Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 134: Australia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Australia Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Australia 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 137: Australia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Australia Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Australia 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • INDIA
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 140: India Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: India Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: India 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 143: India Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: India Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: India 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 146: South Korea Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: South Korea Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: South Korea 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 149: South Korea Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: South Korea Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: South Korea 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 152: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Asia-Pacific Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Asia-Pacific 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Asia-Pacific Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Asia-Pacific 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 158: Latin America Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 159: Latin America Historic Review for Intravenous Infusion Pumps by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Latin America 15-Year Perspective for Intravenous Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 161: Latin America Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Latin America Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Latin America 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 164: Latin America Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Latin America Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Latin America 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 167: Argentina Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Argentina Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Argentina 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 170: Argentina Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Argentina Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Argentina 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 173: Brazil Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Brazil Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Brazil 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 176: Brazil Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Brazil Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Brazil 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 179: Mexico Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Mexico Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Mexico 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 182: Mexico Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Mexico Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Mexico 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 185: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Latin America Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Latin America 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Latin America Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Latin America 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 191: Middle East Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 192: Middle East Historic Review for Intravenous Infusion Pumps by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Middle East 15-Year Perspective for Intravenous Infusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 194: Middle East Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Middle East Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Middle East 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 197: Middle East Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Middle East Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Middle East 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 200: Iran Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Iran Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Iran 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 203: Iran Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Iran Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Iran 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 206: Israel Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Israel Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Israel 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 209: Israel Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Israel Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Israel 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 212: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Saudi Arabia Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Saudi Arabia 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 215: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Saudi Arabia Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Saudi Arabia 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 218: UAE Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: UAE Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: UAE 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 221: UAE Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: UAE Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: UAE 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 224: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Middle East Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Middle East 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 227: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Middle East Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Middle East 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030
  • AFRICA
    • Intravenous Infusion Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 230: Africa Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Africa Historic Review for Intravenous Infusion Pumps by Product - Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Africa 15-Year Perspective for Intravenous Infusion Pumps by Product - Percentage Breakdown of Value Sales for Volumetric Infusion Pumps, Insulin Infusion Pumps, Syringe Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia, Implantable Infusion Pumps and Other Products for the Years 2015, 2025 & 2030
    • TABLE 233: Africa Recent Past, Current & Future Analysis for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Africa Historic Review for Intravenous Infusion Pumps by Disease Indication - Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Africa 15-Year Perspective for Intravenous Infusion Pumps by Disease Indication - Percentage Breakdown of Value Sales for Diabetes, Gastroenterology, Analgesia / Pain Management, Pediatrics / Neonatology, Hematology, Other Disease Indications and Chemotherapy for the Years 2015, 2025 & 2030

IV. COMPETITION